Cargando…
The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective
The human kinome is one of the most productive classes of drug target, and there is emerging necessity for treating complex diseases by means of polypharmacology (multi-target drugs and combination products). However, the advantages of the multi-target drugs and the combination products are still un...
Autores principales: | Li, Ying Hong, Wang, Pan Pan, Li, Xiao Xu, Yu, Chun Yan, Yang, Hong, Zhou, Jin, Xue, Wei Wei, Tan, Jun, Zhu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102354/ https://www.ncbi.nlm.nih.gov/pubmed/27828998 http://dx.doi.org/10.1371/journal.pone.0165737 |
Ejemplares similares
-
Quantitative analysis on the characteristics of targets with FDA approved drugs
por: Sakharkar, Meena K., et al.
Publicado: (2007) -
Novel targeted drugs approved by the NMPA and FDA in 2019
por: Wang, Wenjing, et al.
Publicado: (2020) -
Identification of FDA-approved drugs targeting the Farnesoid X Receptor
por: van de Wiel, Sandra M. W., et al.
Publicado: (2019) -
Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens
por: Hussein, Maytham, et al.
Publicado: (2020) -
Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks
por: Xu, Jingyu, et al.
Publicado: (2016)